Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Malononitrilamide compound prolongs islet xenograft survival in combination with ciclosporin

Nov. 5, 1999

Cantab and Glaxo Wellcome initiate phase II trials for DISC HSV vaccine

Nov. 5, 1999

Brequinar + ciclosporin for islet xenograft rejection: results using a pig-to-rat model

Nov. 4, 1999

Combinations of ERL-080A, RAD and/or ciclosporin prolong heart xenograft survival

Nov. 4, 1999

ImClone receives payment from AHP for gonorrhea vaccine milestone

Nov. 4, 1999

Potential new approach to xenotransplantation: WF-10-containing combinations

Nov. 3, 1999

CA-074: a cathepsin B inhibitor with potential in xenotransplantation

Nov. 3, 1999

Combination of FTY-720 and ciclosporin inhibits pig islet xenograft rejection in rats

Nov. 3, 1999

FDA approves IND for North American Vaccine's Hib vaccine

Nov. 3, 1999

Rigel and Novartis enter collaboration to discover B-cell mediators

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...